About Rubicon Research Ltd
Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products.
Founded
1999
CEO
CHANGAVALLI VENKAT
Employees
1,885
HQ
Thane (West), Maharashtra
Finished Products
1Sales
₹3,179.82Cr2Other Operating Income
₹23.97Cr3Sale of Services
₹10.34Cr4Export benefits
₹10.09Cr5Royalty Income
₹9.60CrRaw Materials
1Cost of materials Consumed
₹700.30CrAbout Rubicon Research Ltd
Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products.
Founded:1999
CEO:CHANGAVALLI VENKAT
Employees:1,885
HQ:Thane (West), Maharashtra
Finished Products
1Sales
₹3,179.82Cr2Other Operating Income
₹23.97Cr3Sale of Services
₹10.34Cr4Export benefits
₹10.09Cr5Royalty Income
₹9.60CrRaw Materials
1Cost of materials Consumed
₹700.30CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,899
52W Low
₹571
Volume123.14K
Avg VolumeN/A
BetaN/A
Dividend Yield0.08%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
104.54x
Valuation
P/B Ratio
23.38x
Valuation
EPS
₹17.41
Valuation
Dividend Yield
0.08%
Valuation
ROE
19.14%
Profitability
ROCE
22.56%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
1.3%
International
98.7%
USA97.4%
Others1.3%
India1.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.24x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
27.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.